Endothelial IFI16 drives vasculopathy and profibrotic remodeling in systemic sclerosis by activating JAK/STAT signaling.

OBJECTIVE: Systemic sclerosis (SSc) is characterized by a prominent type I interferon (IFN-I) signature, yet the upstream drivers that link this signature to fibrosis remain unclear. This study aims to identify Interferon gamma-inducible protein 16 (IFI16) as an endothelial mediator that contributes to vasculopathy and fibrotic remodeling in SSc. METHODS: Machine-learning screening of public bulk RNA-seq was applied to identify fibrosis-associated IFN-I regulators. IFI16 expression pattern was validated by scRNA-seq, spatial transcriptomics and immunofluorescence. Functional and pathway analyses were performed in IFI16-overexpressing endothelial cells. RESULTS: A machine-learning-based analysis of bulk RNA-seq datasets demonstrated that IFI16 is significantly upregulated in SSc skin and ranks among the IFN-I-associated genes positively correlated with more severe skin fibrosis, shorter non-Raynaud disease duration, and elevated extracellular matrix deposition. Single-cell and spatial transcriptomic analyses revealed the enrichment of IFI16 in endothelial cells, and the co-localization of IFI16 with vasculature was validated by immunofluorescence. IFI16-high endothelial cells exhibited higher IFN activity and enhanced extracellular matrix remodeling. Stimulation with profibrotic or proinflammatory cytokines (IL-6, IL-1β, TGF-β and IFN-⍺) upregulated IFI16 expression in endothelial cells. Gain-of-function experiments showed that IFI16 overexpression impaired endothelial proliferation, migration, and tube formation, while driving the transition of endothelial cells towards mesenchymal cells through JAK-STAT signaling. Inhibition of JAK-STAT signaling reversed IFI16-induced endothelial-mesenchymal transition. CONCLUSION: Collectively, endothelial IFI16 coupled IFN-I signaling to vasculopathy and fibrotic remodeling via JAK-STAT activation, highlighting IFI16 as a promising therapeutic target in SSc vasculopathy and the subsequent fibrosis.

Authors

Institutions

Publication Details

Journal
PubMed
Published
2026-11-12
DOI
https://doi.org/10.1093/rheumatology/keag626
Primary Topic
Systemic Sclerosis and Related Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Endothelial IFI16 drives vasculopathy and profibrotic remodeling in systemic sclerosis by activating JAK/STAT signaling.

Hejian Zou, Lingbiao Wang, Wenjing Ye, Yiyun Yu et al.
PubMed
Systemic Sclerosis and Related Diseases
article

Endothelial IFI16 drives vasculopathy and profibrotic remodeling in systemic sclerosis by activating JAK/STAT signaling.

Hejian Zou, Lingbiao Wang, Wenjing Ye, Yiyun Yu, Tim Filla, Fangfang Chen, Linlin Huang, Weiguo Wan, Jiucun Wang, Xiaoxia Zhu, Xue Yang, Chen Chen, Yi-Nan Li, Yu Xue, Ling Cao
article en

Abstract

OBJECTIVE: Systemic sclerosis (SSc) is characterized by a prominent type I interferon (IFN-I) signature, yet the upstream drivers that link this signature to fibrosis remain unclear. This study aims to identify Interferon gamma-inducible protein 16 (IFI16) as an endothelial mediator that contributes to vasculopathy and fibrotic remodeling in SSc. METHODS: Machine-learning screening of public bulk RNA-seq was applied to identify fibrosis-associated IFN-I regulators. IFI16 expression pattern was validated by scRNA-seq, spatial transcriptomics and immunofluorescence. Functional and pathway analyses were performed in IFI16-overexpressing endothelial cells. RESULTS: A machine-learning-based analysis of bulk RNA-seq datasets demonstrated that IFI16 is significantly upregulated in SSc skin and ranks among the IFN-I-associated genes positively correlated with more severe skin fibrosis, shorter non-Raynaud disease duration, and elevated extracellular matrix deposition. Single-cell and spatial transcriptomic analyses revealed the enrichment of IFI16 in endothelial cells, and the co-localization of IFI16 with vasculature was validated by immunofluorescence. IFI16-high endothelial cells exhibited higher IFN activity and enhanced extracellular matrix remodeling. Stimulation with profibrotic or proinflammatory cytokines (IL-6, IL-1β, TGF-β and IFN-⍺) upregulated IFI16 expression in endothelial cells. Gain-of-function experiments showed that IFI16 overexpression impaired endothelial proliferation, migration, and tube formation, while driving the transition of endothelial cells towards mesenchymal cells through JAK-STAT signaling. Inhibition of JAK-STAT signaling reversed IFI16-induced endothelial-mesenchymal transition. CONCLUSION: Collectively, endothelial IFI16 coupled IFN-I signaling to vasculopathy and fibrotic remodeling via JAK-STAT activation, highlighting IFI16 as a promising therapeutic target in SSc vasculopathy and the subsequent fibrosis.

PubMed
Chinese Academy of Medical Sciences & Peking Union Medical College (CN), Fudan University (CN), Düsseldorf University Hospital (DE), Zhongshan Hospital (CN), Huashan Hospital (CN), Union Hospital (CN), State Key Laboratory of Genetic Engineering (CN), Heinrich Heine University Düsseldorf (DE)
Good health and well-being
Systemic Sclerosis and Related Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon